Literature DB >> 1336223

Serotonergic signalling between thyroid cells: protein kinase C and 5-HT2 receptors in the secretion and action of serotonin.

H Tamir1, S C Hsiung, P Y Yu, K P Liu, M Adlersberg, E A Nunez, M D Gershon.   

Abstract

Parafollicular (PF) cells of the thyroid gland are neural crest derivatives, which costore the neurotransmitter, 5-hydroxytryptamine (5-HT) with calcitonin. PF cells are located adjacent to follicular (F) cells within the basement membrane of thyroid follicles. It has been proposed that 5-HT serves an intercellular signalling function in the thyroid and that F cells are its target. This proposal was tested by using cell lines derived from PF (medullary thyroid carcinoma [MTC]) and F (FRTL-5) cells to study the mechanisms that mediate the secretion and action of 5-HT. Secretion of 5-HT by MTC cells was evoked by thyroid stimulating hormone, thyrotropin (TSH), elevated extracellular calcium (increases [Ca2+]e), or by agents that increase intracellular cAMP (increases [cAMP]i). When protein kinase C (PKC) was down-regulated by prolonged treatment of MTC cells with phorbol 12-myristate 13-acetate (PMA), or PKC was inhibited by staurosporin, the TSH- or PMA-evoked secretion of 5-HT was blocked; however, interference with PKC function did not affect 5-HT secretion evoked by increases [Ca2+]e or increases [cAMP]i. In the putative targets, FRTL-5 cells, 5-HT increased the turnover of phosphoinositides (PI), cytosolic calcium (increases [Ca2+]i), increases [cAMP]i, and biphasically modified the effect of TSH on cAMP. All of these 5-HT effects were inhibited by 5-HT2 receptor antagonists (spiperone and ketanserin) and by pertussis toxin (PTx), suggesting that the actions of 5-HT are mediated by 5-HT2 receptors, which are coupled to a G protein. This suggestion was supported by the following additional observations: FRTL-5 membranes bound the 5-HT2 agonist, [125I]2,5-dimethoxy-4-iodophenylisopropylamine ([125I]-DOI), and anti-idiotypic antibodies, which recognize 5-HT2 receptors. [125I]-DOI binding was inhibited by guanosine-5'-O-(3-thiotriphosphate) (GTP-gamma-S) and the antibodies were displaced by spiperone. Data are consistent with the hypothesis that 5-HT serves as a PF to F cell messenger.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336223     DOI: 10.1002/syn.890120209

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  6 in total

1.  C cells evolve at the same rhythm as follicular cells when thyroidal status changes in rats.

Authors:  Inés Martín-Lacave; María J Borrero; José C Utrilla; José M Fernández-Santos; Manuel de Miguel; Jesús Morillo; Juan M Guerrero; Rocío García-Marín; Esperanza Conde
Journal:  J Anat       Date:  2009-03       Impact factor: 2.610

2.  Mechanism of extracellular Ca2+ receptor-stimulated hormone release from sheep thyroid parafollicular cells.

Authors:  D S McGehee; M Aldersberg; K P Liu; S Hsuing; M J Heath; H Tamir
Journal:  J Physiol       Date:  1997-07-01       Impact factor: 5.182

Review 3.  Thyroid parafollicular cells. An accessible model for the study of serotonergic neurons.

Authors:  A F Russo; M S Clark; P L Durham
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

4.  Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis.

Authors:  Jesús Morillo-Bernal; José M Fernández-Santos; José C Utrilla; Manuel de Miguel; Rocío García-Marín; Inés Martín-Lacave
Journal:  J Anat       Date:  2009-06-01       Impact factor: 2.610

5.  Reversible Fluoxetine-Induced Hyperthyroidism: A Case Report.

Authors:  Jianbo Lai; Dongrong Xu; Bradley S Peterson; Yi Xu; Ning Wei; Minming Zhang; Shaohua Hu
Journal:  Clin Neuropharmacol       Date:  2016 Jan-Feb       Impact factor: 1.592

6.  Elevated K+ channel activity opposes vasoconstrictor response to serotonin in cerebral arteries of the Fawn Hooded Hypertensive rat.

Authors:  Mallikarjuna R Pabbidi; Richard J Roman
Journal:  Physiol Genomics       Date:  2016-10-27       Impact factor: 3.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.